|
|
|
Insider
Information: |
Lyle Corinne H |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
146,030 |
|
Indirect Shares
|
2,600 |
|
|
Direct
Value |
$7,397,558 |
|
|
Indirect Value
|
$77,025 |
|
|
Total
Shares |
148,630 |
|
|
Total
Value |
$7,474,583 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
CVP & Pres., Global Ops |
2010-05-11 |
16,687 |
2010-02-11 |
2,600 |
Premium* |
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2008-05-28 |
0 |
Premium* |
|
Avanir Pharmaceuticals |
AVNR |
Director |
2014-02-12 |
80,050 |
2013-03-11 |
0 |
Premium* |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2018-05-07 |
43,283 |
2013-03-28 |
0 |
Premium* |
|
Insulet Corp |
PODD |
Director |
2023-05-23 |
6,010 |
2019-01-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2008-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900 |
29,656 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2016-05-03 |
4 |
D |
$45.05 |
$46,041 |
D/D |
(1,022) |
30,555 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2016-05-03 |
4 |
OE |
$3.07 |
$46,050 |
D/D |
15,000 |
31,577 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2009-11-09 |
4 |
OE |
$30.43 |
$304,300 |
D/D |
10,000 |
32,559 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2010-02-11 |
4 |
OE |
$30.43 |
$304,300 |
D/D |
10,000 |
32,559 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2009-10-27 |
4 |
OE |
$30.43 |
$304,300 |
D/D |
10,000 |
32,809 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2017-05-05 |
4 |
AS |
$53.98 |
$269,900 |
D/D |
(5,000) |
34,603 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2008-11-18 |
4 |
OE |
$30.43 |
$260,511 |
D/D |
8,561 |
35,537 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2008-08-07 |
4 |
OE |
$30.43 |
$304,300 |
D/D |
10,000 |
36,857 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2008-10-23 |
4 |
OE |
$30.43 |
$304,300 |
D/D |
10,000 |
36,976 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2008-11-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
38,015 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP & Pres., Global Ops |
|
2008-11-21 |
4 |
OE |
$30.43 |
$348,089 |
D/D |
11,439 |
38,415 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2017-05-03 |
4 |
D |
$53.37 |
$50,808 |
D/D |
(952) |
39,603 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2017-05-03 |
4 |
OE |
$3.40 |
$51,000 |
D/D |
15,000 |
40,555 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-05-07 |
4 |
AS |
$83.13 |
$415,625 |
D/D |
(5,000) |
43,283 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-05-02 |
4 |
D |
$80.08 |
$105,706 |
D/D |
(1,320) |
48,283 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Director |
|
2018-05-02 |
4 |
OE |
$7.05 |
$105,750 |
D/D |
15,000 |
49,603 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
Director |
|
2013-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
58,350 |
58,350 |
0 |
- |
|
AVNR |
Avanir Pharmaceuticals |
Director |
|
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
80,050 |
0 |
- |
|
69 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|